Research

The latest research news from UNC Health Care and the UNC School of Medicine.

Meet UNC School of Medicine’s COVID-19 Research Heroes

Meet UNC School of Medicine’s COVID-19 Research Heroes

The UNC School of Medicine has researchers across disciplines working together to combat the COVID-19 pandemic.

Meet UNC School of Medicine’s COVID-19 Research Heroes - Read More…

Food Lion Donates $500,000 to UNC Health for COVID-19 Research

Food Lion Donates $500,000 to UNC Health for COVID-19 Research

The North Carolina-based retailer donated $3.1 million this week for local hunger-relief efforts and COVID-19 research on vaccines and treatments at UNC Health and the UNC School of Medicine.

Food Lion Donates $500,000 to UNC Health for COVID-19 Research - Read More…

Worldwide Study Unlocks Genetic Secrets of Gray Matter

Worldwide Study Unlocks Genetic Secrets of Gray Matter

A major international collaboration co-led by UNC School of Medicine scientist Jason Stein, PhD, has produced the first genetic map of the cerebral cortex, identifying more than 300 genetic variants that influence cortical structure and play roles in psychiatric conditions.

Worldwide Study Unlocks Genetic Secrets of Gray Matter - Read More…

Research for Me @UNC – Do I have to list my study?

Research for Me @UNC – Do I have to list my study?

Research for Me allows potential participants to reach out directly to you to indicate their interest in your study. We have over 11,000 registered users who are ready to get involved in research at UNC.

Research for Me @UNC – Do I have to list my study? - Read More…

UNC Researchers Look to Next Generation Genetic Sequencing for Deeper Understanding of COVID-19

UNC Researchers Look to Next Generation Genetic Sequencing for Deeper Understanding of COVID-19

Dirk Dittmer, PhD, professor of microbiology and immunology, is working with colleagues to explore how next generation sequencing can be used to help ensure accuracy in novel coronavirus diagnostics, as well as identify mutations and learn the history of the virus by sequencing its genome.

UNC Researchers Look to Next Generation Genetic Sequencing for Deeper Understanding of COVID-19 - Read More…

COVID-19 Research Preparedness Website

The School of Medicine Office of Research now has a COVID-19 Research Preparedness Website that provides resources and information from both federal institutions and UNC-Chapel Hill.

COVID-19 Research Preparedness Website - Read More…

AskBio, UNC-Chapel Hill Collaborate on Angelman Syndrome Gene Therapy Research

AskBio, UNC-Chapel Hill Collaborate on Angelman Syndrome Gene Therapy Research

A UNC School of Medicine research team led by Mark Zylka, PhD, and Ben Philpot, PhD, has generated preclinical evidence that gene therapy may help individuals with Angelman syndrome by improving seizure and motor outcomes.

AskBio, UNC-Chapel Hill Collaborate on Angelman Syndrome Gene Therapy Research - Read More…

Office of Research Bi-Annual Report

The SOM OoR 2019-20 Academic Year Bi-Annual Report summarizes important news and accomplishments from June 2019 through January 2020.

Office of Research Bi-Annual Report - Read More…

Temporary UNC Policy on Human Subjects-Related Research Visits at UNC-Chapel Hill during COVID-19 Outbreak

In light of recent State of North Carolina and University statements on COVID-19 and the rapidly evolving outbreak, UNC-Chapel Hill is issuing a temporary policy related to human subjects-related research visits.

Temporary UNC Policy on Human Subjects-Related Research Visits at UNC-Chapel Hill during COVID-19 Outbreak - Read More…

Newer Anti-HIV Drugs Safest, Most Effective During Pregnancy

Newer Anti-HIV Drugs Safest, Most Effective During Pregnancy

Dolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women. UNC’s Lameck Chinula presented findings at the online Conference on Retroviruses and Opportunistic Infections. UNC’s Jeffrey Stringer is a study investigator.

Newer Anti-HIV Drugs Safest, Most Effective During Pregnancy - Read More…

Virtual Reality Shows Promise for Early Detection of MS Balance Problems

Virtual Reality Shows Promise for Early Detection of MS Balance Problems

The UNC School of Medicine lab of Jason Franz, PhD, created virtual reality experiments to show how a potentially portable and inexpensive test could reduce falls and related injuries in people with multiple sclerosis.

Virtual Reality Shows Promise for Early Detection of MS Balance Problems - Read More…

Scientists Create Tool to Detect Genes Associated with Psychiatric, Neurodegenerative Diseases

Scientists Create Tool to Detect Genes Associated with Psychiatric, Neurodegenerative Diseases

Led by UNC School of Medicine neuroscientist Hyejung Won, PhD, researchers created H-MAGMA, a computational tool that improves current technology used to link non-coding genetic variants to the genes associated with diseases through genome-wide association studies.

Scientists Create Tool to Detect Genes Associated with Psychiatric, Neurodegenerative Diseases - Read More…

CAR-T immunotherapy for lymphoma studied at UNC Lineberger receives fast-track designation from FDA

CAR-T immunotherapy for lymphoma studied at UNC Lineberger receives fast-track designation from FDA

Based on proof-of-concept results from clinical trials at UNC Lineberger Comprehensive Cancer Center and Baylor College of Medicine, an investigational cellular immunotherapy for Hodgkin lymphoma has received a Regenerative Medicine Advanced Therapy designation from the U.S. Food and Drug Administration.

CAR-T immunotherapy for lymphoma studied at UNC Lineberger receives fast-track designation from FDA - Read More…

ViiV Healthcare, UNC-Chapel Hill announce five-year, $20 million renewal of HIV cure partnership

ViiV Healthcare, UNC-Chapel Hill announce five-year, $20 million renewal of HIV cure partnership

This unique public-private collaboration provides funding for HIV Cure Center and Qura Therapeutics, the joint venture that brings academic and pharmaceutical research scientists together for the goal of curing people with HIV. David Margolis, MD, is the director of the UNC Cure Center.

ViiV Healthcare, UNC-Chapel Hill announce five-year, $20 million renewal of HIV cure partnership - Read More…

Five-year survival improves for certain cancers in adolescents and young adults

Five-year survival improves for certain cancers in adolescents and young adults

UNC Lineberger's Hazel Nichols, PhD, is senior author of a report in the Journal of the National Cancer Institute that shows which cancer types saw improved outcomes among adolescents and young adults.

Five-year survival improves for certain cancers in adolescents and young adults - Read More…

New age nicotine

New age nicotine

As a wave of vaping-related deaths was thrust into the spotlight last year, researchers at the UNC School of Medicine and colleagues at Carolina have become experts in all areas of the field from pulmonology to marketing.

New age nicotine - Read More…

NIH Phase II Small Business Research Grant Awarded to EpiCypher and UNC physicians; Drs. Saira Sheikh and Nigel Key.

NIH Phase II Small Business Research Grant Awarded to EpiCypher and UNC physicians; Drs. Saira Sheikh and Nigel Key.

Dr. Saira Sheikh of the UNC Thurston Arthritis Research Center and Dr. Nigel Key of the UNC Blood Research Center partnered with local biotech company EpiCypher® for the successful Grant, funded by NIAID. The total award to EpiCypher® is $3 million dollars over three years, with just under a $1 million sub-award to UNC.

NIH Phase II Small Business Research Grant Awarded to EpiCypher and UNC physicians; Drs. Saira Sheikh and Nigel Key. - Read More…

Limited Submissions' Internal Call for Proposals : NIH Childhood Asthma in Urban Settings -Clinical Research Centers

Limited Submissions: Internal Call for Proposals  National Institute of Health Childhood Asthma in Urban Settings -Clinical Research Centers (U01 Clinical Trial Optional) UNC Internal deadline: 11:59PM, Monday, April 6, 2020.

Limited Submissions' Internal Call for Proposals : NIH Childhood Asthma in Urban Settings -Clinical Research Centers - Read More…

Limited Submissions' Internal Call for Proposals : NIH Shared Instrumentation for Animal Research (SIFAR) Grant Program

Limited Submissions: Internal Call for Proposals  National Institutes of Health Shared Instrumentation for Animal Research (SIFAR) Grant Program (S10 Clinical Trial Not Allowed) UNC Internal deadline: 11:59PM, Monday, April 6, 2020.

Limited Submissions' Internal Call for Proposals : NIH Shared Instrumentation for Animal Research (SIFAR) Grant Program - Read More…

Share This: